Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cytosorbents (CTSO) Return on Sales (2016 - 2025)

Cytosorbents (CTSO) has disclosed Return on Sales for 14 consecutive years, with 0.37% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 5.0% year-over-year to 0.37%, compared with a TTM value of 0.32% through Sep 2025, down 38.0%, and an annual FY2024 reading of 0.46%, down 23.0% over the prior year.
  • Return on Sales was 0.37% for Q3 2025 at Cytosorbents, up from 0.44% in the prior quarter.
  • Across five years, Return on Sales topped out at 1.77% in Q4 2023 and bottomed at 1.5% in Q3 2022.
  • Average Return on Sales over 5 years is 0.51%, with a median of 0.44% recorded in 2025.
  • The sharpest move saw Return on Sales surged 185bps in 2023, then plummeted -206bps in 2024.
  • Year by year, Return on Sales stood at 0.86% in 2021, then soared by 91bps to 0.08% in 2022, then soared by 2269bps to 1.77% in 2023, then tumbled by -116bps to 0.29% in 2024, then dropped by -27bps to 0.37% in 2025.
  • Business Quant data shows Return on Sales for CTSO at 0.37% in Q3 2025, 0.44% in Q2 2025, and 0.17% in Q1 2025.